-+ 0.00%
-+ 0.00%
-+ 0.00%

SLING THERAPEUTICS: FIRST PATIENTS DOSED IN GLOBAL PHASE 3 ORBIT PIVOTAL TRIAL OF LINSITINIB FOR THYROID EYE DISEASE

Reuters·09/16/2026 11:00:00

Please log in to view news